Harrow Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Harrow Inc's ROI in the second quarter of 2026?
Harrow Inc recorded a cumulative net loss of $-37 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -11.98%.

Within the Healthcare sector 11 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2862 to 2863.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	50.44 %	4.14 %	-17.63 %	-15.6 %	-20.42 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	315	328	303	297	96
Return On Investment (TTM)	-11.98 %	-5.85 %	-2.36 %	-2.3 %	-4.95 %
HROW's Overall Ranking	# 2863	# 2862	# 2171	# 2083	# 2334
Seq. Investment Change TTM	21.4 %	17.29 %	0.64 %	4.98 %	-15.96 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-37	-15	-5	-5	-10

HROW Company Profile >> Back to HROW Roi Comparisons >> See Annual HROW Return On Investment

Return On Investment HROW's Ranking
Within:	No.
Industry	# 3
Sector	# 12
Overall	# 2863

Return On Investment Statistics
High	Average	Low
22.41 %	-45.88 %	-153.75 %
(Mar 31 2021)		(Dec 31 2015)

News about Harrow Inc Return on Investment ROI

Harrow Inc. to Engage Investors Amid Ongoing Financial Challenges

November 15, 2024

Harrow Inc. (Nasdaq: HROW) Announces Participation in Upcoming Conferences NASHVILLE, Tenn. October 2023 Harrow Inc. a prominent eyecare pharmaceutical company based in North America, has announced its participation in three key investor conferences in the coming months. The management team will engage with investors at the Craig-Hallum 15th Annual Alpha Select Conference, scheduled for November 19, 2024, at the Sheraton New York Times Square Hotel, exclusively through one-on-one meetings. Following this, Harrow will take part in the BTIG 4th Annual Ophthalmology Day, a virtual event set for December 2, 2024, also featuring one-on-one virtual meetings. Lastly, the company plans to attend the Piper Sandler 36th Annual Healthcare Conference, which will occur at The Lotte New York Palace, further solidifying its commitment to maintaining investor relations.Despite its proactive stance in engaging with investors, Harrow is facing significant financial headwinds. The company reported a cumulative net loss of $31 million for the twelve months ending in the first quarter of 2024, resulting in a negative return on investment (ROI) of -12.75%. This disconcerting figure positions Harrow at a disadvantage compared to 262 other companies in the healthcare sector that achieved a higher ROI. Nonetheless, Harrow s overall ranking for ROI has shown some improvement, climbing to the 3,067th position as of March 31, 2024, up from 3,243rd in the previous quarter. This relative advancement could indicate a slight rebound in performance, despite the ongoing challenges faced by the company.

Financial Statements
Harrow Inc's II. Quarter Investments	$ 315 Millions	HROW's Balance sheet
Harrow Inc's II. Quarter Income	$ -17 Millions	Quarterly HROW's Income Statement
HROW's Income by Division		See HROW's Income by Division

HROW Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	303	297	262	138	88
Y / Y Investment Growth	1.87 %	13.26 %	89.65 %	56.81 %	90.53 %
Net Income in Millions	-5	-17	-24	-14	-18
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-1.7 %	-5.88 %	-9.3 %	-10.18 %	-20.4 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
HROW's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for HROW's Competitors
Subscribers only: Roi for Harrow Inc's Suppliers
Subscribers only: Return On Investment for HROW's Customers

Other Ratios
HROW's Roa	HROW's Inventory Turnover Ratio	HROW's Growth Rates	HROW's Dividend Statistics
	HROW's Profitability Ratios	HROW's Asset Turnover Ratio	HROW's Dividend Growth
HROW's Roe	HROW's Valuation Ratios	HROW's Financial Strength Ratios	HROW's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:04:03+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.